We are monitoring the impact of COVID-19 on MEA Active Pharmaceutical Ingredients Market Get in touch with us for detailed analysis Know More
Pulished Date May, 2021
ID: 11568
Share on
Share on

Middle East and Africa Active Pharmaceutical Ingredients Market Analysis Report – Segmented By Type of Manufacturing Process, Type of Synthesis, API Formulation, Application, Molecules & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: May, 2021
ID: 11568
Pages: 90

MEA Active Pharmaceutical Ingredients Market Size (2021 to 2026)

The size of the active pharmaceutical ingredients market is forecasted to be growing at a healthy rate during the forecast period.

The active pharmaceutical ingredients market in the MEA region is one of the lucrative and fast-growing markets in the domain of the pharma industry. The Middle East and African region are an untapped part of the global API market. The main drivers for the market are the rising geriatric population; in the coming ten years, Africa has become the second most populous and aged country globally. In addition to that, due to the fast development happening in the countries of Africa and ME, there is an increased life expectancy in some of the countries of this region. It is increasing non-transmissible chronic diseases like cardiovascular disorders, obesity, and diabetes. Apart from these aspects, the MEA region diversifies the scope for installing the APIs manufacturing units in the region.

As the countries in the region of Africa are experiencing mass urbanization, there is increased spending on health. The Govt of developed nations in these regions like Saudi and other nations import branded products contributing a lot to the APIs market. Govt policies towards the manufacturers of APIs are helping the market to be on a growth trajectory. Due to the availability of cheap labor, manufacturers are looking at these countries to install units over here.

Many of the African countries are poor, and the people in these countries cannot afford to purchase branded medicines with effective APIs. So, there is a huge reliance on Generic drugs, which inhibits the APIs market in the region. Govt protocols, these countries follow borrowed protocols of international bodies, which are barring the API manufacturers in getting regulatory approvals. Hence it is restraining the top global players from creating a market in this region. Due to the increased generics, every country in this region is trying to restrict the global companies' imports and stress them to localize in their countries. This is a big restraint to the companies in the creation of a huge market.

Impact of COVID-19 on the MEA API Market:

Covid-19 has impacted the region in both ways; during the first wave, there was an increased case of COVID-19 in the countries of this region. This escalated the demand for APIs from different countries, and the region has witnessed a supply chain disruption as it is importing APIs from china majorly. In the aftermath of the pandemic, countries of this region are procuring life-saving medicines in large quantities because they are importing APIs and installing APIs manufacturing hubs on a large scale triggering the growth of the APIs market in the region.

This research report on the Middle East and Africa active pharmaceutical ingredients market has been segmented and sub-segmented into the following categories.

By Type of Manufacturing Process:

  • Captive Manufacturing
  • Contract Manufacturing

By Type of Synthesis:

  • Synthetic
  • Biotech

By API Formulation:

  • Generic API
  • Innovative API

By Application:

  • Cardiovascular Diseases
  • Oncology
  • Neurological Disorders
  • Orthopedic Disorders
  • Respiratory
  • Gastrointestinal Disorders
  • Urology
  • Others

By Molecule:

  • Large Molecule
  • Small Molecule

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

In the Middle East and Africa region, there are large disparities in terms of wealth, development, science and technology, and health care. In the middle east countries like Saudi Arabia, Israel, UAE, and other developed countries, health care is very much consolidated, and they spend a lot on health care. Due to the advanced sci & tech development, import APIs for producing branded drugs with world-class facilities. Over 85% of the products are imported from reputed players.

In the case of African nations, the demand for APIs is increasing year on year; when coming to South Africa, the country is incentivizing the APIs production units faster. Nigeria is one of the top pharmaceutical manufacturing countries globally, with a notable share experiencing an average CAGR of 6%. The African region is expected to grow to USD 85 billion by the end of 2025. North African region countries like Tunisia, Morocco, and Egypt also experience notable growth in APIs Industry.

KEY MARKET PLAYERS:

AbbVie Inc., AstraZeneca, Aurobindo Pharma Ltd., BASF, Bayer AG, Boehringer Ingelheim, Dr. Reddy's Laboratories, F. Hoffmann-La Roche, GlaxoSmithKline plc, Lonza Group, Lupin Limited, Merck & Co., Inc., Mylan NV, Novartis International AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. are some of the noteworthy companies in the MEA active pharmaceutical ingredients market.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Type of Manufacturing Process
      1. Captive Manufacturing
      2. Contract Manufacturing
      3. Y-o-Y Growth Analysis, By Manufacturing Process
      4. Market Attractiveness Analysis, By Manufacturing Process
      5. Market Share Analysis, By Manufacturing Process
    2. By Type of Synthesis
      1. Synthetic
      2. Biotech
      3. Y-o-Y Growth Analysis, By Type of Synthesis
      4. Market Attractiveness Analysis, By Type of Synthesis
      5. Market Share Analysis, By Type of Synthesis
    3. By API Formulation
      1. Generic API
      2. Innovative API
      3. Y-o-Y Growth Analysis, By API Formulation
      4. Market Attractiveness Analysis, By API Formulation
      5. Market Share Analysis, By API Formulation
    4. By Application
      1. Cardiovascular Diseases
      2. Oncology
      3. Neurological Disorders
      4. Orthopedic Disorders
      5. Respiratory
      6. Gastrointestinal Disorders
      7. Urology
      8. Others
      9. Y-o-Y Growth Analysis, By Application
      10.  Market Attractiveness Analysis, By Application
      11.  Market Share Analysis, By Application
    5. By Molecule
      1. Large Molecule
      2. Small Molecule
      3. Y-o-Y Growth Analysis, By Molecule
      4. Market Attractiveness Analysis, By Molecule
      5. Market Share Analysis, By Molecule
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
    2. Middle East and Africa
      1. Introduction
      2. ·       KSA
      3. ·       UAE
      4. ·       Israel
      5. ·       rest of GCC countries
      6. ·       South Africa
      7. ·       Ethiopia
      8. ·       Kenya
      9. ·       Egypt
      10. ·       Sudan
      11. ·       rest of MEA
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Sanofi
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Bayer AG
    3. Pfizer Inc.
    4. F. Hoffmann-La Roche AG
    5. Abbott Laboratories
    6. Merck & Co., Inc.
    7. Boehringer Ingelheim GmbH
    8. Glaxosmithkline Plc (GSK)
    9. Novartis AG
    10. Eli Lilly and Company
    11. Teva Pharmaceutical Industries Ltd
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and also identify the regions that are still untapped.
  • The segment-level analysis in terms of the type of manufacturing process, type of synthesis, API formulation, application, molecules along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market, which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Middle East and Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturing process, From 2021 to 2026 (USD Million)
  2. Middle East and Africa Captive Manufacturing Market, By Region, From 2021 to 2026 (USD Million)
  3. Middle East and Africa Contract Manufacturing Market, By Region, From 2021 to 2026 (USD Million)
  4. Middle East and Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, From 2021 to 2026 (USD Million)
  5. Middle East and Africa Synthetic Market, By Region, From 2021 to 2026 (USD Million)
  6. Middle East and Africa Biotech Market, By Region, From 2021 to 2026 (USD Million)
  7. Middle East and Africa Active Pharmaceutical Ingredients Market, By API Formulation, From 2021 to 2026 (USD Million)
  8. Middle East and Africa Generic API Market, By Region, From 2021 to 2026 (USD Million)
  9. Middle East and Africa Innovative API Market, By Region, From 2021 to 2026 (USD Million)
  10. Middle East and Africa Active Pharmaceutical Ingredients Market, By Application, From 2021 to 2026 (USD Million)
  11. Middle East and Africa Cardiovascular Diseases Market, By Region, From 2021 to 2026 (USD Million)
  12. Middle East and Africa Oncology Market, By Region, From 2021 to 2026 (USD Million)
  13. Middle East and Africa Neurological Disorders Market, By Region, From 2021 to 2026 (USD Million)
  14. Middle East and Africa Orthopaedic Disorders Market, By Region, From 2021 to 2026 (USD Million)
  15. Middle East and Africa Respiratory Market, By Region, From 2021 to 2026 (USD Million)
  16. Middle East and Africa Gastrointestinal Disorders Market, By Region, From 2021 to 2026 (USD Million)
  17. Middle East and Africa Urology Market, By Region, From 2021 to 2026 (USD Million)
  18. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Million)
  19. Middle East and Africa Active Pharmaceutical Ingredients Market, By Molecule, From 2021 to 2026 (USD Million)
  20. Middle East and Africa Large Molecule Market, By Region, From 2021 to 2026 (USD Million)
  21. Middle East and Africa Small Molecule Market, By Region, From 2021 to 2026 (USD Million)
  22. Middle East Active Pharmaceutical Ingredients Market, By Type of Manufacturing process, From 2021 to 2026 (USD Million)
  23. Middle East Active Pharmaceutical Ingredients Market, By Type of Synthesis, From 2021 to 2026 (USD Million)
  24. Middle East Active Pharmaceutical Ingredients Market, By API Formulation, From 2021 to 2026 (USD Million)
  25. Middle East Active Pharmaceutical Ingredients Market, By Application, From 2021 to 2026 (USD Million)
  26. Middle East Active Pharmaceutical Ingredients Market, By Molecule, From 2021 to 2026 (USD Million)
  27. Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturing process, From 2021 to 2026 (USD Million)
  28. Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, From 2021 to 2026 (USD Million)
  29. Africa Active Pharmaceutical Ingredients Market, By API Formulation, From 2021 to 2026 (USD Million)
  30. Africa Active Pharmaceutical Ingredients Market, By Application, From 2021 to 2026 (USD Million)
  31. Africa Active Pharmaceutical Ingredients Market, By Molecule, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample